Origin Ventures

Founders and existing shareholders in startups have used an assumption for the last decade that is suddenly no longer true, and it means unexpected dilution for everyone.

AI is fundamentally reshaping drug discovery, disease modeling, and patient stratification - but the datasets that powered previous waves of biomedical breakthroughs won’t carry the next wave. High-quality, structured, real-world clinical data is now the scarce input gating progress. Most of it is t

The hardest-working metal parts in the world (landing gear, hypersonic leading edges, undersea actuators, high-performance brakes) share a common weakness: their surfaces. For decades, the fix has been the same: add something on top. Paint, plating, thermal spray, PVD. Every one of those is a coatin

The page recounts a Google team member announcing that he and his wife were expecting their third child, then saying he would provide dates for his planned absence, including Family Medical Leave.

Alex joined Origin Ventures in 2019 after serving as SAP’s vice president for global business development and holding roles at Deloitte and House of Blues. He founded and chairs Harvard Business School Alumni Angels of Chicago.

Brent joined Origin Ventures in January 2013, and leads the firm’s office in Salt Lake City.

Bruce N. Barron is a Founding Partner of Origin Ventures.

Jason joined Origin Ventures in 2014 and began his career in venture capital in 2001.

Origin Ventures invests in founders in the Artificial Intelligence Economy.

The privacy notice describes users’ privacy rights and choices and states that people who disagree with its policies and practices should not use its services.